MECP2 Mutation Interrupts Nucleolin–mTOR–P70S6K Signaling in Rett Syndrome Patients

Overview of attention for article published in Frontiers in Genetics, December 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 8,397 followers.

RT @Epigenetica: New in Pubmed: "MECP2 Mutation Interrupts Nucleolin-mTOR-P70S6K Signaling in Rett Syndrome Patients." https://t.co/YTTP2zm…

New in Pubmed: "MECP2 Mutation Interrupts Nucleolin-mTOR-P70S6K Signaling in Rett Syndrome Patients." https://t.co/YTTP2zmsQh

RT @FrontGenetics: MECP2 Mutation Interrupts Nucleolin–mTOR–P70S6K Signaling in Rett Syndrome Patients: Carl O. Olson, Shervin Pejhan, Dani…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.